Bin Yang

发表

Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.

Gang Chen, E. Guo, Zhenkun Wang, 2021, Gynecologic oncology.

BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages

Junbo Hu, Kezhen Li, Gang Chen, 2020, Frontiers in Immunology.

Inhibiting the IRE1α Axis of the Unfolded Protein Response Enhances the Antitumor Effect of AZD1775 in TP53 Mutant Ovarian Cancer

G. Mills, Weiqi Wang, Gang Chen, 2022, Advanced science.

Integrating pathology, chromosomal instability and mutations for risk stratification in early-stage endometrioid endometrial carcinoma

L. Xi, D. Ma, Ling Feng, 2020, Cell & Bioscience.

Integrative analysis of the common genetic characteristics in ovarian cancer stem cells sorted by multiple approaches

Changyu Wang, Xiaoxiao Zhang, Bin Yang, 2020, Journal of Ovarian Research.

Mutation profiles in circulating cell‐free DNA predict acquired resistance to olaparib in high‐grade serous ovarian carcinoma

Gang Chen, Qicai Zhou, Zizhuo Wang, 2022, Cancer science.

Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant—a Chinese retrospective cohort study among 148 cases

Kezhen Li, Jing Chen, Nan Yu, 2018, Frontiers of Medicine.

Do the Residual Lung Lesions Threaten Gestational Trophoblastic Neoplasia Patients?

Kezhen Li, Yan Zhang, Qian Sun, 2018, International Journal of Gynecologic Cancer.

mTOR inhibition overcomes primary and acquired resistance to Wee1 inhibition by augmenting replication stress in epithelial ovarian cancers.

L. Xi, Gang Chen, Zizhuo Wang, 2020, American journal of cancer research.

AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway.

Li Zhang, Gang Chen, Xu Qin, 2021, Cancer letters.

Synergistic effect of PARP inhibitor and BRD4 inhibitor in multiple models of ovarian cancer

Li Zhang, Gang Chen, Zizhuo Wang, 2021, Journal of cellular and molecular medicine.

Is ICI-based therapy better than chemotherapy for metastatic NSCLC patients who develop EGFR-TKI resistance? A real-world investigation

Gang Chen, Wei Zhang, Junhong Zhang, 2022, Frontiers in Oncology.

MEK Inhibition Remodels the Immune Landscape of Mutant KRAS Tumors to Overcome Resistance to PARP and Immune Checkpoint Inhibitors

G. Mills, G. Peng, Leng Han, 2021, Cancer Research.

Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis

Gang Chen, Zizhuo Wang, Di Hu, 2022, Cell reports. Medicine.

Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19

Chaolong Wang, Kezhen Li, D. Ma, 2020, Annals of Internal Medicine.

Fecal microbiota transplantation mitigates vaginal atrophy in ovariectomized mice

L. Xi, D. Ma, Rajluxmee Beejadhursing, 2021, Aging.

Immunotherapy-Related Cardiotoxicity Re-Emergence in Non-Small Cell Lung Cancer – A Case Report

Bin Yang, Hui Ren, Yan-ping Hu, 2021, OncoTargets and therapy.

The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer

Li Zhang, Zizhuo Wang, Xu Qin, 2022, Frontiers in Immunology.

Multi-omics characterization of silent and productive HPV integration in cervical cancer

B. Kong, Gang Chen, Di Hu, 2023, Cell genomics.

The trans-omics landscape of COVID-19

Huanming Yang, Xin Jin, Xun Xu, 2020, Nature Communications.

Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumors

D. Ma, Zizhuo Wang, Xu Qin, 2021, Aging.

Differential immune responses in pregnant patients recovered from COVID-19

Kezhen Li, Jing Chen, Haiyi Liu, 2021, Signal Transduction and Targeted Therapy.

Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection

Kezhen Li, Gang Chen, Peng Wu, 2020, Nature Communications.

Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis

D. Ma, Yifan Meng, Jia Liu, 2020, Journal of Hematology & Oncology.

Lapatinib-induced inhibition of ovarian function is counteracted by the STAT3 pathway both in vivo and in vitro

Kezhen Li, Jing Chen, Bin Yang, 2020, Oncology Report.

Codelivery of adavosertib and olaparib by tumor-targeting nanoparticles for augmented efficacy and reduced toxicity.

Li Zhang, Di Hu, Xu Qin, 2022, Acta biomaterialia.

WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway

G. Mills, Yiling Lu, D. Ma, 2021, The Journal of experimental medicine.

Immune Response to COVID-19 During Pregnancy

Kezhen Li, Jing Chen, Haiyi Liu, 2021, Frontiers in Immunology.

Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial Ovarian Carcinoma: A Multicenter Retrospective Study

Kezhen Li, Yan Zhang, Xinyu Wang, 2020, Current Medical Science.

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors

G. Mills, Di Hu, Xu Qin, 2023, Journal for ImmunoTherapy of Cancer.

Clinical characteristics and survival of patients with normal-sized ovarian carcinoma syndrome: Retrospective analysis of a single institution 10-year experiment

Kezhen Li, Jing Chen, Nan Yu, 2020, World journal of clinical cases.

MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC

Di Hu, Chaoyang Sun, Junpeng Fan, 2023, Cell & Bioscience.

Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer.

Gang Chen, Zhenkun Wang, Bin Yang, 2021, Gynecologic oncology.

Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance

Kezhen Li, Chaoyang Sun, Junpeng Fan, 2023, Nature Genetics.